Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Benchmark Holdings hail 'excellent quarter' as aquaculture biotechnology firm continue 'journey'

Benchmark Holdings hail 'excellent quarter' as aquaculture biotechnology firm continue 'journey'

Trond Williksen, CEO & Septima Maguire, CFO Benchmark Holdings PLC (AIM:BMK) (Benchmark Holdings PLC (AIM:BMK)) talk to Proactive London about their trading which was in line with expectations following a good performance in the final quarter of 2021.

Group revenues were up 38% year-on-year with all three parts of the business showing “good growth”: Advance Nutrition (+26%); Genetics +20% and Health (+347%).

All divisions were profitable in the quarter, contributing to underlying earnings (EBITDA) of £7.4mln, up 145% on the same period of the previous year. The EBITDA margin in the period surged to 18.6% from 10.4% the year before.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK